Growth Metrics

Bruker (BRKR) EPS (Weighted Average and Diluted) (2016 - 2026)

Bruker filings provide 16 years of EPS (Weighted Average and Diluted) readings, the most recent being $0.1 for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 11.11% to $0.1 in Q4 2025 year-over-year; TTM through Dec 2025 was -$0.15, a 119.74% decrease, with the full-year FY2025 number at -$0.15, down 119.74% from a year prior.
  • EPS (Weighted Average and Diluted) hit $0.1 in Q4 2025 for Bruker, up from -$0.41 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.4 in Q4 2023 to a low of -$0.41 in Q3 2025.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $0.38 (2021), compared with a mean of $0.37.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): soared 428.57% in 2021 and later crashed 251.85% in 2025.
  • Bruker's EPS (Weighted Average and Diluted) stood at $0.49 in 2021, then soared by 34.69% to $0.66 in 2022, then skyrocketed by 112.12% to $1.4 in 2023, then plummeted by 93.57% to $0.09 in 2024, then increased by 11.11% to $0.1 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were $0.1 (Q4 2025), -$0.41 (Q3 2025), and $0.05 (Q2 2025) per Business Quant data.